Shexiang Baoxin Pill Alleviates the Atherosclerotic Lesions in Mice via Improving Inflammation Response and Inhibiting Lipid Accumulation in the Arterial Wall

Epidemiological studies have demonstrated that cardiovascular diseases (CVDs) are the leading cause of death in the world. Atherosclerosis, a kind of chronic vascular disorder related to multiple pathogenic processes, has been reported to be an underlying cause of CVDs. Shexiang Baoxin Pill (SBP) is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mediators Inflamm
Autors principals: Lu, Li, Qin, Yating, Zhang, Xinxin, Chen, Chen, Xu, Xiangyu, Yu, Chingwen, Guo, Xiaomei
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657610/
https://ncbi.nlm.nih.gov/pubmed/31379468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6710759
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars